Ranodeep Chatterjee , PhD
Ranodeep Chatterjee is a molecular and cell biologist with a strong research focus on tumor heterogeneity, cancer immunology, and host-microbiome interactions. He currently holds a position as a Postdoctoral Researcher at the Laboratory of Host-Microbiome Interactions at the Nencki Institute of Experimental Biology, Polish Academy of Sciences in Warsaw, Poland. He received his PhD in Zoology from the University of Calcutta (2024), where he also earned his MSc in Neuroscience and BSc in Microbiology.
Academic and Research Appointments:
- 2025 - present: Postdoctoral Researcher, Nencki Institute of Experimental Biology, Warsaw, Poland
- 2019 - 2020: Junior Research Assistant, Department of Zoology, University of Calcutta, India
- 2016 - 2019: Research Project Fellow and Teaching Assistant, Charuchandra College (University of Calcutta)
- 2014 - 2015: Research Project Fellow, Department of Zoology, University of Calcutta
Dr Chatterjee's research spans cancer biology, cellular signaling pathways, autophagy and inflammation in tumor progression, epigenetic regulation, and the influence of the gut microbiota on immune response and therapeutic resistance. He has contributed to several funded research projects across academic and translational settings in India and now in Europe.
Honors and awards:
- Young Investigator Award, Cancer Foundation of India (2022)
- M.M. Chakraborty Memorial Medal, Zoological Society of Kolkata (2022)
- Certificate in Multiparameter Flow Cytometry and Clinical Applications, BD Biosciences (2023)
Selected publications:
- Chatterjee, R. et al. (2023), CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation. Frontiers in Oncology, 13, 1242432. DOI: 10.3389/fonc.2023.1242432
- Chatterjee, R., Chatterji, U. (2022), CLEC12A: A Promise Target for Cancer Therapy. Archives of Clinical and Medical Case Reports, 6(5), 548. DOI: 10.26502/acmcr.96550548
- Bhattacharya, R., Chatterjee, R., et al. (2021), Theaflavin-containing black tea extract: a potential DNA methyltransferase inhibitor..., Nutrition and Cancer. DOI: 10.1080/01635581.2020.1828943
- Das, S., Mukherjee, P., Chatterjee, R., et al. (2019), Enhancing chemosensitivity of breast cancer stem cells..., Molecular Cancer Therapeutics. DOI: 10.1158/1535-7163.mct-18-0409
- Maji, P., Chatterjee, R., et al. (2017), Enhanced p53-dependent growth inhibition of human glioblastoma cells..., nternational Journal of Pharmacy and Pharmaceutical Sciences. DOI: 10.22159/ijpps.2017v9i6.18002
